Skip to main content
Premium Trial:

Request an Annual Quote

Kirk Malloy

NanoString Technologies has appointed Kirk Malloy to its Board of Directors. Malloy brings 20 years of experience in the life science tools, applied markets, and molecular diagnostics markets. He is the founder of consulting firm BioAdvisors, and was previously senior VP and general manager of life sciences and applied markets at Illumina. Prior to that, Malloy worked at Biosite and Qiagen. He also sits on the boards of publicly traded Organovo Holdings and the privately-held firms Edico Genome, iGenomx, and Agilome. 

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.